The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome

Roberta MelchionnaTumour Immunology and Immunotherapy Unit, Regina Elena National Cancer Institute, Rome, Italy

Pierluigi IapiccaTumour Immunology and Immunotherapy Unit, Regina Elena National Cancer Institute, Rome, Italy

Francesca Di ModugnoTumour Immunology and Immunotherapy Unit, Regina Elena National Cancer Institute, Rome, Italy

Paola TronoTumour Immunology and Immunotherapy Unit, Regina Elena National Cancer Institute, Rome, Italy

Isabella SperdutiBiostatistics and Scientific Direction, Regina Elena National Cancer Institute, Rome, Italy

Matteo FassanARC-NET Research Center, Department of Pathology and Diagnostics, University of Verona, Verona, Italy

Ivana CataldoARC-NET Research Center, Department of Pathology and Diagnostics, University of Verona, Verona, Italy

Borislav C. RusevARC-NET Research Center, Department of Pathology and Diagnostics, University of Verona, Verona, Italy

Rita T. LawlorARC-NET Research Center, Department of Pathology and Diagnostics, University of Verona, Verona, Italy

Maria Grazia DiodoroPathology Unit, Regina Elena National Cancer Institute, Rome, Italy

Michele MilellaMedical Oncology, Regina Elena National Cancer Institute, Rome, Italy

Gian Luca GraziHepato-pancreato-biliary Surgery Unit, Regina Elena National Cancer Institute, Rome, Italy

Mina J. BissellLawrence Berkeley National Laboratory, University of California, CA, USA

Aldo ScarpaARC-NET Research Center, Department of Pathology and Diagnostics, University of Verona, Verona, Italy

Paola NisticòTumour Immunology and Immunotherapy Unit, Regina Elena National Cancer Institute, Rome, ItalyCorrespondence[email protected]

Your download is now in progress and you may close this window